|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Mr. Murray S. Kessler||CEO, Pres & Director||3,22M||N/D||1960|
|Mr. Raymond P. Silcock||CFO, Principal Accounting Officer & Exec. VP||1,36M||N/D||1951|
|Mr. Todd W. Kingma||Exec. VP, Gen. Counsel & Sec.||1,1M||N/D||1960|
|Mr. Svend Andersen||Exec. VP & Pres of Consumer Healthcare International||1,12M||N/D||1962|
|Mr. Richard S. Sorota||Exec. VP & Pres of Consumer Self-Care Americas||1,1M||N/D||1963|
|Mr. Ronald C. Janish||Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain||N/D||N/D||1966|
|Mr. Shannon Hukill||Sr. Director of Technical Operations||N/D||N/D||N/D|
|Mr. Thomas M. Farrington||Chief Information Officer & Exec. VP||N/D||N/D||1957|
|Mr. James E. Dillard III||Exec. VP & Chief Scientific Officer||N/D||N/D||1964|
|Mr. Bradley Joseph||VP of Global Investor Relations & Corp. Communications||N/D||N/D||N/D|
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
L'ISS Governance QualityScore di Perrigo Company plc al 30 aprile 2021 è 5. I criteri di valutazione fondamentali sono revisione: 3; Consiglio di Amministrazione: 8; diritti degli azionisti: 4; retribuzione: 6.